Rifampin-isoniazid oligonucleotide typing: An alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 48, Issue 12, 2010, Pages 4386-4391

  Hernández Neuta, Iván ^a   Varela, Andrés ^a   Martin, Anandi ^b   Von Groll, Andrea ^b   Jureen, Pontus ^c   López, Beatriz ^d   Imperiale, Belén ^e   Šķenders, Ģirts ^f   Ritacco, Viviana ^d   Hoffner, Sven ^c   Morcillo, Nora ^e   Palomino, Juan Carlos ^b   Del Portillo, Patricia ^a  

^a Genomics and Evolution of Communities of Environmental Microorganisms   (Colombia)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^e Hospital Zonal de Agudos y Cronicos Dr Antonio A Cetrangolo   (Argentina)

^f State Agency of Tuberculosis and Lung Diseases   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ISONIAZID; KATG PROTEIN; OLIGONUCLEOTIDE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; INHA GENE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDES; OXIDOREDUCTASES; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 78650061157     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00448-10     Document Type: Article

References (33)

1. Argyrou, A., M. W. Vetting, and J. S. Blanchard. 2007. New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP. J. Am. Chem. Soc. 129:9582-9583.
2. Bostanabad, S. Z., L. P. Titov, A. Bahrmand, and S. A. Nojoumi. 2008. Detection of mutation in isoniazid-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. Indian J. Med. Microbiol. 26:143-147.
3. Brossier, F., N. Veziris, C. Truffot-Pernot, V. Jarlier, and W. Sougakoff. 2006. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J. Clin. Microbiol. 44:3659-3664.
4. Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9:67.
5. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ. 41:21-43.
6. Canetti, G., S. Froman, J. Grosset, P. Hauduroy, M. Langerova, H. T. Mahler, G. Meissner, D. A. Mitchison, and L. Sula. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 29:565-578.
7. Cole, S. T., and A. Telenti. 1995. Drug resistance in Mycobacterium tuberculosis. Eur. Respir. J. Suppl. 20:701s-713s.
8. Cowan, L. S., L. Diem, M. C. Brake, and J. T. Crawford. 2004. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J. Clin. Microbiol. 42:474-477.
9. Feuerman, M., and A. R. Miller. 2008. Relationships between statistical measures of agreement: sensitivity, specificity and kappa. J. Eval. Clin. Pract. 14:930-933.
10. Jureen, P., J. Werngren, and S. E. Hoffner. 2004. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb.) 84:311-316.
11. Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35:907-914.
12. Kapetanaki, S. M., S. Chouchane, S. Yu, X. Zhao, R. S. Magliozzo, and J. P. Schelvis. 2005. Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. Biochemistry 44:243-252.
13. Kong, F., and G. L. Gilbert. 2006. Multiplex PCR-based reverse line blot hybridization assay (mPCR/RLB) - a practical epidemiological and diagnostic tool. Nat. Protoc. 1:2668-2680.
14. Kremer, K., M. van Zetten, J. van Embden, L. Shouls, and D. van Soolingen. 2003. "RIFO ASSAY": a PCR + reverse line blot hybridization method to detect rifampin resistance. National Institute of Public Health and Environment, Bilthoven, Netherlands.
15. Landis, J. R., and G. G. Koch. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
16. Martin, A., F. Portaels, and J. C. Palomino. 2007. Colorimetric redoxindicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J. Antimicrob. Chemother. 59:175-183.
17. Miller, L. P., J. T. Crawford, and T. M. Shinnick. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:805-811.
18. Mokrousov, I., N. V. Bhanu, P. N. Suffys, G. V. Kadival, S. F. Yap, S. N. Cho, A. M. Jordaan, O. Narvskaya, U. B. Singh, H. M. Gomes, H. Lee, S. P. Kulkarni, K. C. Lim, B. K. Khan, D. van Soolingen, T. C. Victor, and L. M. Schouls. 2004. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J. Microbiol. Methods 57:323-335.
19. Morcillo, N., M. Zumarraga, A. Alito, A. Dolmann, L. Schouls, A. Cataldi, K. Kremer, and D. van Soolingen. 2002. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 6:959-965.
20. Napolitano, N. M., E. M. Rohlfs, and R. A. Heim. 2004. Simultaneous detection of multiple point mutations using allele-specific oligonucleotides. Curr. Protoc. Hum. Genet., chapter 9, unit 9.4. doi:10.1002/0471142905. hg0904s41.
21. Palomino, J. C. 2009. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 56:103-111.
22. Sandgren, A., M. Strong, P. Muthukrishnan, B. K. Weiner, G. M. Church, and M. B. Murray. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e2.
23. Senna, S. G., H. M. Gomes, M. O. Ribeiro, A. L. Kristki, M. L. Rossetti, and P. N. Suffys. 2006. In house reverse line hybridization assay for rapid detection of susceptibility to rifampicin in isolates of Mycobacterium tuberculosis. J. Microbiol. Methods 67:385-389.
24. Shenai, S., C. Rodrigues, and A. Mehta. 2009. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. Int. J. Infect. Dis. 13:46-58.
25. Siddiqi, S. H., J. P. Libonati, and G. Middlebrook. 1981. Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 13:908-912.
26. Suresh, N., U. B. Singh, J. Arora, J. N. Pande, P. Seth, and J. C. Samantaray. 2006. Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by in-house, reverse line blot assay. Diagn. Microbiol. Infect. Dis. 56:133-140.
27. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
28. Van Deun, A., A. Martin, and J. C. Palomino. 2010. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int. J. Tuberc. Lung Dis. 14:131-140.
29. Vilcheze, C., and W. R. Jacobs, Jr. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61:35-50.
30. Vilcheze, C., F. Wang, M. Arai, M. H. Hazbon, R. Colangeli, L. Kremer, T. R. Weisbrod, D. Alland, J. C. Sacchettini, and W. R. Jacobs, Jr. 2006. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med. 12:1027-1029.
31. World Health Organization. 2009. Global tuberculosis control: a short update to the 2009 report. World Health Organization, Geneva, Switzerland.
32. Yu, S., S. Girotto, C. Lee, and R. S. Magliozzo. 2003. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. J. Biol. Chem. 278:14769-14775.
33. Zhang, S. L., J. G. Shen, P. H. Xu, D. X. Li, Z. Q. Sun, L. Li, Z. R. Yang, and Q. Sun. 2007. A novel genotypic test for rapid detection of multidrugresistant Mycobacterium tuberculosis isolates by a multiplex probe array. J. Appl. Microbiol. 103:1262-1271.